top of page


From £149 (4 weekly doses)

weight management medication


Wegovy is indicated for weight management in patients, in conjunction with a reduced-calorie diet and increased physical activity.

About the Service:

Objectives of treatment

This treatment is used to reduce the Body Mass Index (BMI) in obese patients (BMI 30+) or in overweight patients (BMI of 27-30) with one or more weight-related co-morbidities.

Who is this treatment available to?

  • Patients aged between 18 and 74 years.

  • Patients with an initial BMI of 30 or greater.

  • Patients in which a supervised diet, behaviour modification and increasing physical activity failed to achieve a realistic reduction in weight.

  • Patients with an initial BMI of 27 or greater in the presence of at least one weight-related comorbidity such as:

̵ Hypertension (High blood pressure)

̵ Dyslipidaemia (abnormal amount of lipids - 'bad' cholesterol in your blood.

̵ Obstructive sleep apnoea

̵ Type 2 diabetes mellitus)

This treatment is only available for ages between 18 and 74 years.

Furthermore, Any Cancellation within 48 hours prior to appointment will incur a charge of 20% of total service cost.

bottom of page